Medvi
MEDVi, LLC is one of the first reported[1] companies to use artificial intelligence technology to create a "one-person unicorn business" (a solo billion-dollar business), similar to what Sam Altman had predicted.[2][3][4]
Founding
Begun in September 2024 by Matthew Gallagher with no employees and outsourcing all other non-AI services, he hired 1 employee in April 2025, then 7 more in September of 2025..[1]
Finances
The first full year of business, in 2025, had revenue and profit around $400M and $65M respectively; projected 2026 profits and revenue are ~$75M and $1.8B, repspectively..[1]
Telehealth business practices
FDA warning
Other companies in similar telehealth service platforms are Hello Cake and Lovely Meds (which have been found to use the same medical groups for business such as Open Loop Health, Beluga Health, MD Integrations, and Telegra)[5] have, along with Hims & Hers Health, have been warned by the FDA of falsely equating their compounded drugs to similar brand-name drugs that are FDA-approved, thus implying that their compounded drugs are also FDA-approved.[6][7]
AI marketing
Advertising and marketing by MEDVi shows AI images of products and patients (before-and-after weightloss)[8] but MEDVi does include a disclaimer saying ""Individuals appearing in advertisements may be actors or AI portraying doctors and are not licensed medical professionals."[6]
External links
References
- ↑ 1.0 1.1 1.2 Griffith, Erin (2 April 2026). "How A.I. Helped One Man (and His Brother) Build a $1.8 Billion Company". The New York Times. Retrieved 6 April 2026.
- ↑ Sawers, Paul (1 February 2025). "AI agents could birth the first one-person unicorn — but at what societal cost?". TechCrunch.
- ↑ Ohanian, Alexis. "Interview with OpenAI CEO Sam Altman by Alexis Ohanian". X.com account of Alexis Ohanian.
- ↑ Minevich, Mark (20 August 2025). "The Billion-Dollar Company Of One Is Coming Faster Than You Think". Forbes.
- ↑ Palmer, Katie (12 March 2026). "The FDA is targeting telehealth marketing of GLP-1 drugs. Who's prescribing them?". STAT.
- ↑ 6.0 6.1 Buntz, Brian (4 April 2026). "The New York Times spotlighted MEDVi. The FDA had already warned the self-proclaimed 'fastest growing company in history.'". Drug Discovery and Development. WTWH Media.
- ↑ "MEDVi, LLC dba MEDVi - 721455 - 02/20/2026". FDA. Center for Drug Evaluation and Research. 3 March 2026.
- ↑ Dupré, Maggie Harrison (29 May 2025). "This Sleazy GLP-1 Prescription Site Is Using Deepfaked "Before-and-After" Photos of Fake Patients, and Running Ads Showing AI-Generated Ozempic Boxes". Futurism.
 | This business-related article is a stub. You can help EverybodyWiki by expanding it. |
This article "Medvi" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Medvi. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
